REDCARE PHARMACY NV (RDC.DE) Earnings History & Surprises

FRA:RDC • NL0012044747

Current stock price

35.16 EUR
-2.46 (-6.54%)
Last:

RDC.DE Earnings overview

Past quarterly earnings results for REDCARE PHARMACY NV (RDC.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 6, 2026

Last Reported

Most Recent
Release Date
Mar 3, 2026
Period
Q4 / 2025
EPS Reported
-€1.06
EPS Surprise
-108.24%
Revenue Surprise
-1.90%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -1.06 -0.51 -108.24% 19.70% 795M 810.4M -1.90% 17.75%
Q3 2025 -0.36 -0.32 -12.80% -2.86% 719.234M 730.53M -1.55% 25.18%
Q2 2025 0.46 -0.22 313.82% 319.05% 709.189M 717.28M -1.13% 26.49%
Q1 2025 -0.53 -0.72 26.81% - 717.286M 722.84M -0.77% 28.04%
Q4 2024 -1.32 -0.93 -42.68% - 675.137M 690.64M -2.24% 27.07%
Q3 2024 -0.35 -0.66 47.25% - 574.548M 581.98M -1.28% 20.83%
Q2 2024 -0.21 -0.08 -159.90% - 560.674M 380.37M 47.40% 33.53%
Q1 2024 - - 560.216M - 50.56%
Q4 2023 - - 531.318M - 62.09%
Q3 2023 - - 475.5M - 67.14%
Q2 2023 - - 419.9M - 46.20%
Q1 2023 - - 372.1M - 22.08%
Q4 2022 - - 327.8M - 13.82%
Q3 2022 - - 284.5M - 19.59%
Q2 2022 - - 287.2M - 14.70%
Q1 2022 - - 304.8M - 7.29%
Q4 2021 -2.46 -1.29 -90.28% - 288M 293.18M -1.77% 8.80%
Q3 2021 -0.79 -0.49 -59.63% - 237.9M 248.93M -4.43% -0.34%
Q2 2021 - - 250.4M - 7.61%
Q1 2021 - - 284.1M - 22.46%
Q4 2020 - - 264.7M - -
Q3 2020 - - 238.7M - -
Q2 2020 - - 232.7M - -
Q1 2020 - - 232M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

RDC.DE EPS Q2Q GrowthRDC.DE EPS Q2Q GrowthEPS Q2Q Growth Q2/25 Q3/25 Q4/25 0 100 200 300

Revenue Historical Q2Q growth and Acceleration

RDC.DE Revenue Q2Q GrowthRDC.DE Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 0 20 40 60

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
54.90%
Max EPS beat (4)
313.82%
Min EPS beat (4)
-108.24%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-1.34%
Max Revenue beat (4)
-0.77%
Min Revenue beat (4)
-1.90%

Analysis

In the last 4 quarters, RDC.DE has beaten EPS estimates in 2 out of 4 releases
RDC.DE has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, RDC.DE has beaten the EPS estimates by 54.9% on average.
In the last 4 quarters, RDC.DE reported -1.3% below the revenue estimates on average.
RDC.DE Overview RDC.DE Technical Analysis Report RDC.DE Fundamental Analysis Report RDC.DE Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

REDCARE PHARMACY NV / RDC.DE Earnings FAQ

When did REDCARE PHARMACY NV (RDC.DE) report earnings last quarter?

REDCARE PHARMACY NV (RDC.DE) last reported earnings on 3/3/2026.

Can you provide information on whether REDCARE PHARMACY NV beat earnings estimates in the last quarter?

REDCARE PHARMACY NV (RDC.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often REDCARE PHARMACY NV beats earnings estimates?

In the last 4 quarters, REDCARE PHARMACY NV (RDC.DE) has beaten EPS estimates in 2 out of 4 releases.